RMR Wealth Builders
ABBV icon

RMR Wealth Builders’s AbbVie ABBV Stock Holding History

RMR Wealth Builders’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.89M Sell
7,214
-73
-1% -$18.7K 0.11% 89
2026
Q2 		$1.83M Buy
7,287
+111
+2% +$23.9K 0.11% 91
2026
Q1 		$1.56M Sell
7,176
-98
-1% -$21.7K 0.12% 92
2025
Q4 		$1.66M Sell
7,274
-347
-5% -$79K 0.13% 87
2025
Q3 		$1.76M Sell
7,621
-285
-4% -$58K 0.15% 83
2025
Q2 		$1.47M Sell
7,906
-398
-5% -$74K 0.13% 91
2025
Q1 		$1.74M Sell
8,304
-1,605
-16% -$312K 0.18% 76
2024
Q4 		$1.76M Sell
9,909
-375
-4% -$68.9K 0.18% 68
2024
Q3 		$2.03M Sell
10,284
-278
-3% -$51.9K 0.22% 59
2024
Q2 		$1.81M Sell
10,562
-1,448
-12% -$240K 0.21% 60
2024
Q1 		$2.19M Buy
12,010
+1,230
+11% +$212K 0.26% 49
2023
Q4 		$1.67M Buy
10,780
+212
+2% +$30.9K 0.23% 51
2023
Q3 		$1.58M Sell
10,568
-711
-6% -$104K 0.25% 49
2023
Q2 		$1.52M Sell
11,279
-73
-0.6% -$10.7K 0.26% 44
2023
Q1 		$1.81M Sell
11,352
-67
-0.6% -$10.2K 0.34% 37
2022
Q4 		$1.85M Buy
11,419
+292
+3% +$44.8K 0.42% 32
2022
Q3 		$1.49M Sell
11,127
-292
-3% -$41.9K 0.37% 35
2022
Q2 		$1.75M Sell
11,419
-444
-4% -$67.8K 0.44% 36
2022
Q1 		$1.92M Buy
11,863
+1,163
+11% +$169K 0.41% 39
2021
Q4 		$1.45M Buy
10,700
+413
+4% +$48.8K 0.42% 34
2021
Q3 		$1.11M Buy
10,287
+349
+4% +$39.9K 0.33% 49
2021
Q2 		$1.12M Sell
9,938
-419
-4% -$47.2K 0.37% 47
2021
Q1 		$1.12M Buy
10,357
+9,051
+693% +$968K 0.29% 52
2020
Q4 		$140K Sell
1,306
-9,556
-88% -$918K 0.07% 182
2020
Q3 		$951K Buy
10,862
+10,416
+2,335% +$981K 0.25% 67
2020
Q2 		$44K Buy
+446
New +$39.3K 0.04% 236
2019
Q4 		$67K Buy
+758
New +$62.9K 0.06% 204

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

RMR Wealth Builders's ABBV Position: Q3 2026 in Review

RMR Wealth Builders reduced its AbbVie (ABBV) stake by 1% in Q3 2026, selling an estimated $18.7K and leaving 7,214 shares worth $1.89M. The position accounts for 0.11% of the portfolio, ranked #89.

RMR Wealth Builders first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. The position peaked at $2.19M in Q1 2024. 2,709 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • RMR Wealth Builders held 7,214 shares of AbbVie worth $1.89M as of Q3 2026.
  • RMR Wealth Builders sold 73 AbbVie shares in Q3 2026, an estimated $18.7K.
  • AbbVie made up 0.11% of RMR Wealth Builders's portfolio in Q3 2026, its #89 holding.
  • RMR Wealth Builders first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • RMR Wealth Builders's AbbVie position peaked at $2.19M in Q1 2024.
  • 2,709 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on RMR Wealth Builders's 13F filing for Q3 2026, filed 22 Oct 2026.